Enhanced SOCS3 in osteoarthiritis may limit both proliferation and inflammation

References

• Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S, Mankin H, McShane DJ, Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthr. Rheum. 29: 1039–1049.
   PubMed Web of Science ®Google Scholar
• Andriacchi TP, Mündermann A, Smith RL, Alexander EJ, Dyrby CO, Koo S (2004) A framework for the in vivo pathomechanics of osteoarthritis at the knee. Ann. Biomed. Eng. 32: 447–457.
   Google Scholar
• Babon JJ, Nicola NA (2012)The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors 30: 207–219.
   Google Scholar
• Baker K, Grainger A, Niu J, Clancy M, Guermazi A, Crema M, Hughes L, Buckwalter J, Wooley A, Nevitt M, Felson DT (2010) Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann. Rheum. Dis. 69: 1779–1783.
   Google Scholar
• Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B (2005) Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64: 1263–1267.
   PubMed Web of Science ®Google Scholar
• Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr. Cart. 21: 16–21.
   Google Scholar
• Bijlsma JW, Berenbaum F, Lafeber FP (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377: 2115–2126.
   Google Scholar
• Chen B, Qin J, Wang H, Magdalou J, Chen L (2010) Effects of adenovirus-mediated bFGF, IL1Ra and IGF1 gene transfer on human osteoarthritic chondrocytes and osteoarthritis in rabbits. Exp. Mol. Med. 42: 684–695.
   PubMed Web of Science ®Google Scholar
• Chun KS, Surh YJ (2004) Signal transduction pathways regulating cyclo-oxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68: 1089–1100.
   PubMed Web of Science ®Google Scholar
• Civinini R, Nistri L, Martini C, Redl B, Ristori G, Innocenti M (2013) Growth factors in the treatment of early osteoarthritis. Rses Miner. Bone Metab. 10: 26–29.
   Google Scholar
• de Hooge AS, van de Loo FA, Koenders MI, Bennink MB, Arntz OJ, Kolbe T, van den Berg WB (2004) Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthr. Rheum. 50: 2014–2023.
   PubMed Web of Science ®Google Scholar
• Deopurkar R, Ghanim H, Friedman J, Abuaysheh S, Sia CL, Mohanty P, Viswanathan P, Chaudhuri A, Dandona P (2010) Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3 Diabetes Care 33: 991–997.
   PubMed Web of Science ®Google Scholar
• Gao A, Kantarci A, Herrera B, Gao H, Van Dyke TE (2013) A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts. Peer J. 1: e51.
   PubMed Web of Science ®Google Scholar
• Gao W, McGarry T, Orr C, McCormick J, Veale DJ, Fearon U (2016) Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors. Ann. Rheum. Dis. 75: 311–315.
   Google Scholar
• Goldring MB, Marcu KB (2009) Cartilage homeostasis in health and rheumatic diseases. Arthr. Res. Ther. 11: 224.
   Google Scholar
• Hiemer B, Genz B, Jonitz-Heincke A, Pasold J, Wree A, Dommerich S, Bader R (2016) Devitalisation of human cartilage by high hydrostatic pressure treatment: subsequent cultivation of chondrocytes and mesenchymal stem cells on the devitalised tissue. Sci. Rep. 6: 33747.
   Google Scholar
• Huang N, Rizshsky L, Hauck CC, Nikolau BJ, Murphy PA, Birt DF (2012) The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in hypericumperforatum extract is partially dependent on the activation of SOCS3. Phytochemistry 76: 106–116.
   Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier, JP, Fahmi H (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7: 33−42.
   PubMed Web of Science ®Google Scholar
• Kon E, Filardo G, Drobnic M, Madry H, Jelic M, van Dijk N, Della Villa S (2012) Non-surgical management of early knee osteoarthritis. Knee Surg. Sports Traumatol. Arthrosc. 20: 436–449.
   PubMed Web of Science ®Google Scholar
• Levinger I, Levinger P, Trenerry MK, Feller JA, Bartlett JR, Bergman N, McKenna MJ, Cameron-Smith D (2011) Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthr. Rheum. 63: 1343–1348.
   PubMed Web of Science ®Google Scholar
• Liu L, Gu H, Liu H, Jiao Y, Li K, Zhao Y, An L, Yang J (2014) Protective effect of resveratrol against IL-1β-induced inflammatory response on human osteoarthritic chondrocytes partly via the TLR4/MyD88/NF-κB signaling pathway: an “in vitro study.” Int. J. Mol. Sci. 15: 6925–6940.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Pelletier JP, Fahmi H (2003) Cyclooxygenase-2 and prostaglandins in articular tissues. Sem. Arthr. Rheum. 33: 155–167.
   PubMed Web of Science ®Google Scholar
• Mentlein R (2007) Targeting pleiotropin to treat osteoarthritis. Exp. Opin. Ther. Targ. 11: 861–867.
   PubMed Web of Science ®Google Scholar
• Ohishi M, Matsumura Y, Aki D, Mashima R, Taniguchi K, Kobayashi T, Kukita T, Iwamoto Y, Yoshimura A (2005) Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines. J. Immunol. 174: 3024–3031.
   Google Scholar
• Roemer FW, Guermazi A, Felson DT, Niu J, Nevitt MC, Crema MD, Lynch JA, Lewis CE, Torner J, Zhang Y (2011) Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study.Ann. Rheum. Dis .70: 1804–1809.
   PubMed Web of Science ®Google Scholar
• Sandell LJ, Aigner T (2001) Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthr. Res. 3: 107–113.
   PubMedGoogle Scholar
• Sellam J, Berenbaum F (2010) The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol. 6: 625–635.
   PubMed Web of Science ®Google Scholar
• Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, Komiya S, Kosai K, Hanakawa Y, Hashimoto K, Nagata K, Yoshimura A (2001) Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108: 1781–1788.
   PubMed Web of Science ®Google Scholar
• Smeets RL, Veenbergen S, Arntz OJ, Bennink MB, Joosten LA, van den Berg WB, van de Loo FA (2006) A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. Arthr. Rheum. 54: 1518–1528.
   PubMed Web of Science ®Google Scholar
• Smyth NA, Murawski CD, Fortier LA, Cole BJ, Kennedy JG (2013) Platelet-rich plasma in the pathologic processes of cartilage: review of basic science evidence. Arthroscopy 29: 1399–1409.
   PubMed Web of Science ®Google Scholar
• Stacey DW (2003) Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol. 15:158–163.
   PubMed Web of Science ®Google Scholar
• Stahl A, Joyal JS, Chen J, Sapieha P, Juan AM, Hatton CJ, Pei DT, Hurst CG, Seaward, MR, Krah NM, Dennison RJ, Greene ER, Boscolo E, Panigrahy D, Smith LE (2012) SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood 120: 2925–2929.
   PubMed Web of Science ®Google Scholar
• Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A (2011) Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler. Thromb. Vasc. Biol. 31: 980–985.
   PubMed Web of Science ®Google Scholar
• van de Loo FA, Veenbergen S, van den Brand B, Bennink MB, Blaney-Davidson E, Arntz OJ, van Beuningen HM, van der Kraan PM, van den Berg WB (2012) Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function. Arthr. Rheum. 64: 3313–3323.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou H, Han Y, Liu X, Wang M, Wang X, Yin G, Li X, Xiang M (2014) SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. J. Mol. Med. (Berl.) 92: 1257–1269.
   PubMed Web of Science ®Google Scholar
• Wong PK, Egan PJ, Croker BA, O’Donnell K, Sims NA, Drake S, Kiu H, McManus EJ, Alexander WS, Roberts AW, Wicks IP (2006) SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J. Clin. Invest. 116: 1571–1581.
   Google Scholar
• Yamamoto Y, Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappa B pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107: 135–142.
   Google Scholar
• Yang X, Chen L, Xu X, Li C, Huang C, Deng CX (2001) TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153: 35–46.
   Google Scholar
• Yoon HY, Lee EG, Lee H, Cho IJ, Choi YJ, Sung MS, Yoo HG, Yoo WH (2013) Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs. Int. J. Mol. Med. 32: 971–977.
   Google Scholar
• Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T, Miyajima A (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors EMBO J 14: 2816–2826.
   Google Scholar